Oral Clotrimazole In The Treatment Of Füngal Infection

  • R. Y. Cartwright
Part of the Chemotherapy book series (CT, volume 6)


For many years, griseofulvin was the only antifungal anti-biotic which was administered orally. Its usefulness was limited however, by its relative narrow spectrum of activity - effective against the dermatophytes but not against yeasts and systemic mycotic infections. The synthesis of iraidazole derivatives has produced Compounds which have a wide antifungal activity, are effective topically and are absorbed from the gastro intestinal tract.


Spontaneous Pneumothorax Left Lower Lobe Vaginal Candidiasis Yeast Infection Lung Damage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Cartwright, R.Y. Clotrimazole in the treatment of acute and “resistant” vaginal candidiasis. Postgraduate Medical Journal. (Supplement l) 50; 90–92 (1974)PubMedGoogle Scholar
  2. Cartwright, R.Y., Shaldon, C. and Hall, G.H. Urinary candiasis after renal transplantation. British Medical Journal. 2; 351 (1972)PubMedCrossRefGoogle Scholar
  3. Crompton, G.K. and Milne, L.J.R. Treatment of bronchopulmonary aspergillosis with clotrimazole. British Journal of Diseases of the Chest. 67; 301–307 (1973)PubMedCrossRefGoogle Scholar
  4. Tettenborn, D. Toxicity and enzyme inducing activity of clotrimazole. Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakilogie. 266; 468–469 (1970).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1976

Authors and Affiliations

  • R. Y. Cartwright
    • 1
  1. 1.M.B., M.R.C. Path. Pub. Hlth. Lab.Guildford, SurreyUK

Personalised recommendations